Advanced oncology risk oversight for employers
Our oncology patient navigation service can be offered as an additional employer-provided benefit for employees (+/- family members) facing a cancer diagnosis—particularly valuable for self-insured groups where avoidable oncology spend directly impacts their costs.
Cancer: A Disproportionate Healthcare Cost Driver
- Cancer affects ~1–2% of employees
- Drives 10–12% of total healthcare spend
- Primary source of catastrophic claims
- Rising incidence and treatment complexity accelerate costs
The Precision Oncology Gap
- The healthcare system is overwhelmed, and oncologists face increasing volume and complexity
- Precision oncology evolves faster than workflows
- Only 20–60% receive guideline-aligned molecular profiling
- Only ~7% of patients enroll in clinical trials
- Lost access increases cost and worsens outcomes
- Disease progression leads to escalating downstream costs
The Opportunity: Oncology Navigation
- Expert-guided decision support
- Precision medicine and trial optimization
- Better outcomes at lower total cost of care
What Our Oncology Navigation Service Includes
We provide concierge advisory support that helps patients (and their treating teams) operationalize precision oncology and high-value care decisions:
- Precision medicine / molecular profiling advisory (test selection strategy, ordering considerations, interpretation, actionability)
- Clinical trial navigation (trial identification, eligibility screening support, prioritization, and logistics)
- Provider and treatment recommendations (including routing to appropriate subspecialists/centers of excellence)
- Clinical data analysis and decision-ready reporting (medical record synthesis, treatment-path comparisons, key evidence summaries)
- Data-driven side-effect management and supportive/adjunct care considerations
Navigation Changes Outcomes
- Inefficiency drives employer spend
- 2–4× improvement in survival for advanced cancers
- 20% reduction in average cost per case
- 15% avoidance of unnecessary treatments
ROI for Employers
- Patients avoid ineffective therapies
- Clinical trials can offset $6K–$85K per patient
- Earlier treatment optimization can prevent catastrophic claims
Risk Adverse Costing Model
Other companies typically fix contracts upfront as a PEPM premium add-on. Our model is different: we operate as a non-profit and only charge for services used.
Data source: Springbuk Health Intelligence Platform employer claims analysis of approximately 1.7 million covered lives across >1,000 employers (Oct 2019–Sept 2022)